Abstract:Human Immunodeficiency Virus (HIV) remains a significant global health challenge with approximately 38 million people currently having the virus worldwide. Despite advances in treatment development, the virus persists in the human population and still leads to new infections. The virus has a powerful ability to mutate and hide from the human immune system in reservoirs of the body. Current standard treatment with antiretroviral therapy effectively controls viral replication but requires lifelong adherence and does not eradicate the virus. This review explores the potential of Advanced Therapy Medicinal Products as novel therapeutic approaches to HIV, including cell therapy, immunisation strategies and gene therapy. Cell therapy, particularly chimeric antigen receptor T cell therapy, shows promise in preclinical studies for targeting and eliminating HIV-infected cells. Immunisation therapies, such as broadly neutralising antibodies are being investigated to control viral replication and reduce reservoirs. Despite setbacks in recent trials, vaccines remain a promising avenue for HIV therapy development. Gene therapy using technologies like CRISPR/Cas9 aims to modify cells to resist HIV infection or eliminate infected cells. Challenges such as off-target effects, delivery efficiency and ethical considerations persist in gene therapy for HIV. Future directions require further research to assess the safety and efficacy of emerging therapies in clinical trials. Combined approaches may be necessary to achieve complete elimination of the HIV reservoir. Overall, advanced therapies offer new hope for advancing HIV treatment and moving closer to a cure.

Strategies for human immunodeficiency virus cure：current status and future prospects

Recent progress on functional cure for acquired immunodeficiency syndrome

Research progress on HIV latency-reversing agents and its mechanism

Advancements in Developing Strategies for Sterilizing and Functional HIV Cures

HIV Reservoirs and Treatment Strategies toward Curing HIV Infection

HIV-1 functional cure: will the dream come true?

The Rational Combination Strategy of Immunomodulatory Latency Reversing Agents and Novel Immunotherapy to Achieve HIV-1 Cure

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection

Latency reversal and viral clearance to cure HIV-1

Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure

Advancements in Cell-Based Therapies for HIV Cure

Research Progress on Human Immunodeficiency Virus Type 1 Latent Infection Activator

Progress in the Treatment of HIV/AIDS

Research progress on human immunodeficiency virus reservoir and its eradication

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Recent developments in CCR5 regulation for HIV cure

Strategies for HIV-1 suppression through key genes and cell therapy

Treatment of Human Immunodeficiency Virus-1: Current Challenges and Future Perspectives

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

New progress in antiretroviral therapy for HIV-1/AIDS

Advanced Therapies for Human Immunodeficiency Virus